School of Education, Zhengzhou University, Zhengzhou, China.
School of Public Policy and Administration, Xian Jiaotong University, Xian, China.
Int J Health Plann Manage. 2022 Nov;37(6):3218-3237. doi: 10.1002/hpm.3551. Epub 2022 Aug 19.
This study has investigated the impact of healthcare expenditure on life expectancy and morbidity rates in the Association of Southeast Asian Nations to analyse whether health expenditure remains a critical component of improving health status and to determine the threshold value at which health strategy becomes cost-effective from 2000 to 2019.
The techniques employed include the Dynamic Panel Threshold model advanced by Seo et al. (2019) to implement Seo and Shin's (2016) proposed first-differenced generalised method of moments (GMM) estimation. Furthermore, the dynamic system GMM and Pooled Ordinary Least Squares (OLS) techniques were also employed for robustness check.
The findings revealed that healthcare expenditure raises life expectancy and lowers the crude death rate, infant mortality rate, and maternal mortality rate. Therefore, healthcare expenditure is increasing life expectancy and reducing crude death rate, infant mortality rate, and maternal mortality rate. However, when disaggregating the impact, that of public healthcare expenditure is higher than that of private except in the case of infant mortality rate where that of private is higher. In addition, it found that the threshold value at which health strategy becomes cost-effective, thus the amount which the countries should spend for health status improvement is at least 6% and above of their Gross Domestic Product (GDP).
Healthcare expenditure is raising life expectancy and lowering the morbidity rate of the countries. Furthermore, the cost-effective level of the country's healthcare expenditure as a proportion of GDP is 6% and above.
本研究考察了医疗支出对东南亚国家联盟(ASEAN)预期寿命和发病率的影响,以分析卫生支出是否仍然是改善健康状况的关键组成部分,并确定从 2000 年到 2019 年健康战略具有成本效益的阈值。
采用了 Seo 等人(2019 年)提出的动态面板门槛模型,以实施 Seo 和 Shin(2016 年)提出的第一差分广义矩估计(GMM)。此外,还采用了动态系统 GMM 和 pooled 普通最小二乘法(OLS)技术进行稳健性检验。
研究结果表明,医疗支出提高了预期寿命,降低了粗死亡率、婴儿死亡率和孕产妇死亡率。因此,医疗支出正在延长预期寿命并降低粗死亡率、婴儿死亡率和孕产妇死亡率。然而,在细分影响时,公共医疗支出的影响高于私人医疗支出,除了婴儿死亡率,私人医疗支出的影响更高。此外,研究还发现了健康战略具有成本效益的阈值,即国家为改善健康状况而应支出的金额至少应占其国内生产总值(GDP)的 6%。
医疗支出正在提高各国的预期寿命并降低发病率。此外,国家医疗支出占 GDP 的成本效益水平至少为 6%。